Who is the manufacturer of CAPNOSTREAM20P WITH HIFI C02 MONITORING?

Oridion Medical 1987 , Ltd. filed the 510(k) submission for CAPNOSTREAM20P WITH HIFI C02 MONITORING (K123690).

What is the FDA product code for CAPNOSTREAM20P WITH HIFI C02 MONITORING?

CCK. It is classified under 21 CFR 868.1400 as a Class 2 device in the Anesthesiology panel.

What is the regulatory pathway for CAPNOSTREAM20P WITH HIFI C02 MONITORING?

510(k) clearance (submission type: Traditional).

Who can help prepare an FDA 510(k) submission like CAPNOSTREAM20P WITH HIFI C02 MONITORING?

Innolitics — a medical-device software consultancy — provides regulatory and engineering support for FDA 510(k) submissions. See https://innolitics.com/services/510ks/ or contact https://innolitics.com/contact.

CAPNOSTREAM20P WITH HIFI C02 MONITORING

Q: What are the predicate devices for CAPNOSTREAM20P WITH HIFI C02 MONITORING?

Capnostream20p with Smart A/hr & ODI (K112368).

K123690 · Oridion Medical 1987 , Ltd. · CCK · Aug 5, 2014 · Anesthesiology

Device Facts

Record ID	K123690
Device Name	CAPNOSTREAM20P WITH HIFI C02 MONITORING
Applicant	Oridion Medical 1987 , Ltd.
Product Code	CCK · Anesthesiology
Decision Date	Aug 5, 2014
Decision	SESE
Submission Type	Traditional
Regulation	21 CFR 868.1400
Device Class	Class 2
Attributes	Pediatric

Intended Use

The Capnostream®20p combined capnograph/pulse oximeter monitor and its accessories are intended to provide professionally trained health care providers with continuous, non-invasive measurement and monitoring of carbon dioxide concentration of the expired and inspired breath and respiration rate, and with continuous non-invasive monitoring of functional oxygen saturation of arterial hemoqlobin (SpO2) and pulse rate. It is also indicated for continuous noninvasive monitoring of carboxyhemoglobin saturation (measured by an SpCO/SpMet/SpHb sensor), methemoglobin saturation (measured by an SpCO/SpMet/SpHb sensor) and total hemoglobin concentration (measured by an SpCO/SpMet/SpHb sensor). It is intended for use with neonatal, pediatric, and adult patients in hospital-type facilities, intra-hospital transport and home environments. Capnostream®20p is to be operated by qualified healthcare personnel only. The Capnostream®20p monitor provides the clinician with an integrated pulmonary index (IPI). The IPI is based on four parameters provided by the monitor: end tidal carbon dioxide, respiration rate, oxygen saturation and pulse rate. The IPI is a single index of an adult or pediatric patient's ventilatory status displayed on a scale of 1 - 10, where 10 indicates optimal pulmonary status. IPI monitoring displays a single value that represents the patient's pulmonary parameters and alerts clinicians to changes in the patient's pulmonary status. The IPI is an adjunct to, and is not intended to replace, vital sign monitoring. The Capnostream20p HiFi mode provides a measurement of expired carbon dioxide and detects spontaneous breaths for infant/neonatal patients ventilated using high frequency oscillatory ventilation (HFOV).

Device Story

Bedside monitor integrating microMediCO2 capnography and pulse oximetry modules; processes CO2, respiration rate, SpO2, and pulse rate. Features Integrated Pulmonary Index (IPI) algorithm, providing single 1-10 score of ventilatory status. HiFi mode enables CO2 measurement and spontaneous breath detection for infants/neonates on High Frequency Oscillatory Ventilation (HFOV). Operated by qualified healthcare personnel in hospitals, transport, or home. Output displayed on host device; alerts clinicians to changes in pulmonary status. IPI serves as adjunct to vital sign monitoring; assists in clinical decision-making by providing consolidated status index. Benefits include continuous monitoring of complex ventilation states.

Clinical Evidence

Bench testing only. Performance validated using lung simulator system; accuracy of CO2 measurements in HFOV mode verified up to 900 BPM (15 Hz) for both passive and spontaneous breaths. CO2 range tested: 16-76 mmHg; spontaneous respiratory rates: 30, 45, and 60 BPM.

Technological Characteristics

Two-parameter bedside monitor; microMediCO2 capnography and pulse oximetry modules. Standards: ISO 21647, ISO 9919, IEC/EN 60601-1, IEC/EN 60601-1-2, IEC 60601-1-8, ISO 14971, EN 980. Software-based IPI algorithm and HiFi mode for HFOV signal processing.

Indications for Use

Indicated for continuous, non-invasive monitoring of CO2, respiration rate, SpO2, pulse rate, carboxyhemoglobin, methemoglobin, and total hemoglobin in neonatal, pediatric, and adult patients in hospitals, transport, and home settings. HiFi mode indicated for infant/neonatal patients on HFOV.

Regulatory Classification

Identification

A carbon dioxide gas analyzer is a device intended to measure the concentration of carbon dioxide in a gas mixture to aid in determining the patient's ventilatory, circulatory, and metabolic status. The device may use techniques such as chemical titration, absorption of infrared radiation, gas chromatography, or mass spectrometry.

Predicate Devices

Capnostream20p with Smart A/hr & ODI (K112368)

Reference Devices

Capnostream20 (K094012)

Related Devices

K101995 — CAPNOSTREAM 20P WITH MASIMO SPO2 BOARD · Oridion Capnography, Inc. · Jan 11, 2011
K094012 — CAPNOSTREAM20 WITH MICROMEDICO2 MODULE · Oridion Capnography, Inc. · May 12, 2010
K082268 — CAPNOSTREAM20 WITH INTEGRATED PULMONARY INDEX · Oridion Capnography, Inc. · Feb 6, 2009
K112368 — CAPNOSTREAM20P WITH AI/ODI · Oridion Medical 1987 , Ltd. · Jul 19, 2012
K200594 — Capnostream 35 Portable Respiratory Monitor · Oridion Medical 1987 , Ltd. · Apr 27, 2020

Submission Summary (Full Text)

{0}------------------------------------------------ Image /page/0/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a circular emblem with the words "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" arranged around the top half of the circle. Inside the circle is a stylized image of three human profiles facing to the right, stacked on top of each other. Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002 August 5, 2014 Ms Dalia Givony Regulatory Affairs Manager Oridion Medical 1987 Limited 7 Hamarpe Street Har Hotzvim Industrial Park Jerusalem, Israel 91450 Re: K123690 Trade/Device Name: Capnostream® 20p with HiFi CO2 Monitoring Regulation Number: 21 CFR 868.1400 Regulation Name: Carbon Dioxide Gas Analyzer Regulatory Class: II Product Code: CCK Dated: June 15, 2014 Received: June 17, 2014 Dear Ms. Givony: We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. {1}------------------------------------------------ Page 2 - Ms. Givony Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Small Manufacturers, International and Consumer Assistance at its tollfree number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm. Also, please note the regulation entitled. "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance. You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Sincerely yours, # Mary S. Runner -S Erin I. Keith, M.S. Director Division of Anesthesiology, General Hospital, Respiratory, Infection Control and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health Enclosure {2}------------------------------------------------ Response to FDA RFI- Capnostream®20p with HiFi CO2 monitoring - K123690 ## Statement of Indications for Use Capnostream®20p with HiFi CO2 monitoring (This document is not confidential) 510(k) Number (if known) K123690 Device Name: Capnostream®20p with HiFi CO2 monitoring #### Intended Use/ Indication for Use The Capnostream®20p combined capnograph/pulse oximeter monitor and its accessories are intended to provide professionally trained health care providers with continuous, non-invasive measurement and monitoring of carbon dioxide concentration of the expired and inspired breath and respiration rate, and with continuous non-invasive monitoring of functional oxygen saturation of arterial hemoqlobin (SpO2) and pulse rate. It is also indicated for continuous noninvasive monitoring of carboxyhemoglobin saturation (measured by an SpCO/SpMet/SpHb sensor), methemoglobin saturation (measured by an SpCO/SpMet/SpHb sensor) and total hemoglobin concentration (measured by an SpCO/SpMet/SpHb sensor). It is intended for use with neonatal, pediatric, and adult patients in hospital-type facilities, intra-hospital transport and home environments. Capnostream®20p is to be operated by qualified healthcare personnel only. The Capnostream®20p monitor provides the clinician with an integrated pulmonary index (IPI). The IPI is based on four parameters provided by the monitor: end tidal carbon dioxide, respiration rate, oxygen saturation and pulse rate. The IPI is a single index of an adult or pediatric patient's ventilatory status displayed on a scale of 1 - 10, where 10 indicates optimal pulmonary status. IPI monitoring displays a single value that represents the patient's pulmonary parameters and alerts clinicians to changes in the patient's pulmonary status. The IPI is an adjunct to, and is not intended to replace, vital sign monitoring. The Capnostream20p HiFi mode provides a measurement of expired carbon dioxide and detects spontaneous breaths for infant/neonatal patients ventilated using high frequency oscillatory ventilation (HFOV). Prescription Use AND/OR Over-The-Counter Use (Per 21 CFR 801 Subpart D) (21 CFR 801 Subpart C) #### PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED) Concurrence of CDRH, Office of Device Evaluation (ODE) Oridion Medical 1987 Ltd. Todd D. Courtney -S 2014.08.04 14:22:31 -04'00' August 28, 2013 {3}------------------------------------------------ Page 1 of 6 ## 510(k) SUMMARY This summary is being submitted in accordance with the requirements of 21 CFR 807.92 (This section is not confidential) #### DATE THIS SUMMARY WAS PREPARED July 31, 2014 ### SUBMITTER'S NAME AND ESTABLISHMENT ADDRESS: Oridion Medical 1987 Ltd 7 HaMarpe Street, Har Hotzvim Industrial Park, Jerusalem, 91450, Israel ### ESTABLISHMENT REGISTRATION NUMBER 8044004 ## CONTACT PERSON: Dalia Givony, Director of Regulatory Affairs Oridion Medical 1987 Ltd Har Hotzvim Science Based Industrial Park POB 45025 91450 Jerusalem, Israel Telephone: +972-2-589 9115 FAX: +972-2-586-6680 {4}------------------------------------------------ Page 2 of 6 ## DEVICE INFORMATION Trade Name: Capnostream20p with HiFi CO2 monitoring Common Name: Two Parameter Bedside Monitor Classification Name: Capnograph/Pulse Oximeter/Ventilatory Effort Recorder Regulation Number: 21 CFR 868.1400, Carbon dioxide analyzer, (product code CCK) Secondary product codes: DQA and MNR. #### PREDICATE DEVICE Capnostream20p with HiFi CO2 monitoring is substantially equivalent to the following commercially available devices: #### MANUFACTURER DEVICE 510(k) No. Clearance Date Oridion 1987 Medical Ltd Capnostream20p with Smart A/hr &ODI K112368 Julv 19, 2012 #### DEVICE DESCRIPTION The Capnostream20p bedside monitor is a two parameter monitor consisting of a microMediCO2 capnography module and a pulse oximetry module implemented in a host device. The host device displays parameters received from the respective modules and generates alarms when preset alarm thresholds are crossed. The HiFi capnography software feature, presented in this submission, is intended to enable measurement of airway CO2 for infant/neonatal patients during high frequency oscillatory ventilation (HFOV) and detects spontaneous breaths for infant/neonatal patients ventilated using high frequency oscillatory ventilation (HFOV). {5}------------------------------------------------ Page 3 of 6 #### INTENDED USE The Capnostream®20p combined capnograph/pulse oximeter monitor and its accessories are intended to provide professionally trained health care providers with continuous, non-invasive measurement and monitoring of carbon dioxide concentration of the expired and inspired breath and respiration rate, and with continuous non-invasive monitoring of functional oxygen saturation of arterial hemoglobin (SpO2) and pulse rate. It is also indicated for continuous noninvasive monitoring of carboxyhemoglobin saturation (measured by an SpCO/SpMet/SpHb sensor), methemoglobin saturation (measured by an SpCO/SpMet/SpHb sensor) and total hemoglobin concentration (measured by an SpCO/SpMet/SpHb sensor). It is intended for use with neonatal, pediatric, and adult patients in hospital-type facilities, intra-hospital transport and home environments. Capnostream®20p is to be operated by qualified healthcare personnel only. The Capnostream®20p monitor provides the clinician with an integrated pulmonary index (IPI). The IPI is based on four parameters provided by the monitor: end tidal carbon dioxide, respiration rate, oxygen saturation and pulse rate. The IPI is a single index of an adult or pediatric patient's ventilatory status displayed on a scale of 1 - 10. where 10 indicates optimal pulmonary status. IPI monitoring displays a single value that represents the patient's pulmonary parameters and alerts clinicians to changes in the patient's pulmonary status. The IPI is an adjunct to, and is not intended to replace, vital sign monitoring. The Capnostream20p HiFi mode provides a measurement of expired carbon dioxide and detects spontaneous breaths for infant/neonatal patients ventilated using high frequency oscillatory ventilation (HFOV). {6}------------------------------------------------ ## COMPARISON TO PREDICATE DEVICE The Capnostream20p with HiFi CO2 monitoring is substantially equivalent to the predicate Capnostream20p with Smart A/hr ODI™ . | Attribute | Predicate Device: Capnostream20p with Smart A/hr ODI™ (K112368) | Capnostream 20p with HiFi CO2 monitoring | |-------------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------| | Classification | = | Same | | Product Code & Regulation number | 868.1400, Carbon Dioxide Analyzer (Classification CCK) 870.2700 Pulse Oximeter (Classification DQA) 868.2375 Ventilatory Effort Recorder (Classification MNR) | Same | | Intended use | The Capnostream®20p combined capnograph/pulse oximeter monitor and its accessories are intended to provide professionally trained health care providers with continuous, non-invasive measurement and monitoring of carbon dioxide concentration of the expired and inspired breath and respiration rate, and with continuous non-invasive monitoring of functional oxygen saturation of arterial hemoglobin (SpO2) and pulse rate. It is also indicated for continuous non-invasive monitoring of carboxyhemoglobin saturation (measured by an SpCO/SpMet/SpHb sensor), methemoglobin saturation (measured by an SpCO/SpMet/SpHb sensor) and total concentration (measured by an SpCO/SpMet/SpHb sensor). It is intended for use with neonatal, pediatric, and adult patients in hospitals, hospital-type facilities, intra-hospital transport and home environments. The Capnostream®20p monitor provides the clinician with an integrated pulmonary index (IPI). The IPI is based on four parameters provided by the monitor: end tidal carbon | Same. In addition: The Capnostream20p HiFi mode provides a measurement of expired carbon dioxide and detects spontaneous breaths for infant/neonatal patients ventilated using high frequency oscillatory ventilation (HFOV). | | Target population | It is intended for use with neonatal, pediatric, and adult patients. The Smart A/hr and ODI indication for use is for adult patients aged 22 and higher only. | Identical target population for monitoring. In addition HiFi mode is intended for infants and neonates only | | Design | Equivalent to the Capnostream20 described in K094012 | same | | Performance Standards | ISO 21647 ISO 9919 | same | | Safety Standards | IEC/EN 60601-1 IEC/EN 60601-1-2 IEC 60601-1-8 ISO 14971 EN 980 | same | {7}------------------------------------------------ Page 5 of 6 ## PERFORMANCE TESTING The Capnostream20p with HiFi is substantially equivalent to the predicate Capnostream20p with A/hr and ODI. The new device meets the safety and performance standards met by the predicate device. Software testing was performed to validate the performance of the new monitor and its substantial equivalence to the predicate device. The functional features and the intended use of Capnostream20p with HiFi are substantially equivalent to the predicate device. {8}------------------------------------------------ Page 6 of 6 Performance testing conducted on a lung simulator system demonstrated the accuracy of the CO2 measurements in HFOV mode up to a rate of 900 BPM (breaths per minute) (15 Hz) for both passive (ventilator driven) and spontaneous breaths. The testing was conducted for a CO2 range of 16mmHg to 76 mmHg and at spontaneous respiratory rates of 30, 45, and 60 BPM. A hazard analysis was carried out on the Capnostream host monitor displaying the HiFi values. This hazard analysis concluded that any residual risks were judged as acceptable when weighed against the intended benefits of use of the system. ## CONCLUSION The Capnostream20p with the HiFi software feature does not raise any new potential safety risks and is equivalent in performance to the existing legally marketed devices. The minor differences between the Capnostream20p with HiFi and its predicate device raise no issue of safety and effectiveness. Therefore, the device is substantially equivalent to the predicate devices with respect to safety, effectiveness, and intended use.